Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kevin Park

Showing results (11-20 of 282) with videos related to

Pageof 29
Sort By:
Kidney International|June 21, 2013
Role of Nrf2 in protection against acute kidney injuryLuke M Shelton, B Kevin Park, Ian M Copple
The Journal of Allergy and Clinical Immunology|March 1, 2011
Immune pathomechanism of drug hypersensitivity reactionsWerner J Pichler, Dean J Naisbitt, B Kevin Park
BMJ Clinical Evidence|October 20, 2015
Paracetamol (acetaminophen) poisoningB Kevin Park, James W Dear, Daniel J Antoine
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 24, 2012
Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkersJack W Sharkey, Daniel J Antoine, B Kevin Park
Biochemical Society Transactions|November 10, 2015
Value of monitoring Nrf2 activity for the detection of chemical and oxidative stressFiona E Mutter, B Kevin Park, Ian M Copple
Expert Opinion on Drug Metabolism & Toxicology|October 28, 2008
Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the scienceDaniel J Antoine, Dominic P Williams, B Kevin Park
Current Opinion in Drug Discovery & Development|January 5, 2008
Ethnic variation in drug response: implications for the development and regulation of drugsDale E Johnson, B Kevin Park, Dennis A Smith
Hepatology (Baltimore, Md.)|February 5, 2021
Gene Signatures Reduce the Stress of Preclinical Drug Hepatotoxicity ScreeningIan M Copple, B Kevin Park, Christopher E Goldring
Current Opinion in Drug Discovery & Development|February 1, 2005
Editorial overview: safety/toxicity threshold concepts in drug discovery and developmentDale E Johnson, Dennis A Smith, B Kevin Park
Current Opinion in Drug Discovery & Development|February 1, 2006
Editorial overview: safety of drugs can never be absoluteDennis A Smith, Dale E Johnson, B Kevin Park
Pageof 29

Showing results (11-20 of 282) with videos related to

Sort By:
Pageof 29
Kidney International|June 21, 2013
Role of Nrf2 in protection against acute kidney injuryLuke M Shelton, B Kevin Park, Ian M Copple
The Journal of Allergy and Clinical Immunology|March 1, 2011
Immune pathomechanism of drug hypersensitivity reactionsWerner J Pichler, Dean J Naisbitt, B Kevin Park
BMJ Clinical Evidence|October 20, 2015
Paracetamol (acetaminophen) poisoningB Kevin Park, James W Dear, Daniel J Antoine
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 24, 2012
Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkersJack W Sharkey, Daniel J Antoine, B Kevin Park
Biochemical Society Transactions|November 10, 2015
Value of monitoring Nrf2 activity for the detection of chemical and oxidative stressFiona E Mutter, B Kevin Park, Ian M Copple
Expert Opinion on Drug Metabolism & Toxicology|October 28, 2008
Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the scienceDaniel J Antoine, Dominic P Williams, B Kevin Park
Current Opinion in Drug Discovery & Development|January 5, 2008
Ethnic variation in drug response: implications for the development and regulation of drugsDale E Johnson, B Kevin Park, Dennis A Smith
Hepatology (Baltimore, Md.)|February 5, 2021
Gene Signatures Reduce the Stress of Preclinical Drug Hepatotoxicity ScreeningIan M Copple, B Kevin Park, Christopher E Goldring
Current Opinion in Drug Discovery & Development|February 1, 2005
Editorial overview: safety/toxicity threshold concepts in drug discovery and developmentDale E Johnson, Dennis A Smith, B Kevin Park
Current Opinion in Drug Discovery & Development|February 1, 2006
Editorial overview: safety of drugs can never be absoluteDennis A Smith, Dale E Johnson, B Kevin Park
Pageof 29